Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2017, XXIII/3: 117-120 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2017, XXIII/3: 117-120

Title: Pelvic inflammatory disease – from pathogenesis and epidemiology to successful treatment 

Authors: Karwowski R, Kuźlik R. 

More details

05-03-2017

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Pelvic inflammatory disease – from pathogenesis and epidemiology to successful treatment


Karwowski R, Kuźlik R.

EMC Medical Institute SA – Department of Gynecology and Obstetrics, Hospital st. Anna in Piaseczno, Poland

Int Rev Allergol Clin Immunol Family Med, 2017; Vol. 23, No. 3, 117

Pelvic inflammatory disease is a very common problem in clinical practice. It is defined as inflammation of the upper part of the female genitals which include the uterus, fallopian tubes and ovaries. Pelvic inflammatory disease mostly affect young, sexually active women in childbearing age, and by their long-term complications can cause a number of adverse reproductive health consequences, such as infertility and an increased risk of ectopic pregnancy. The most common pathogens causing pelvic inflammatory disease are sexually transmitted organisms – Neisseria gonorrhea and Chlamydophila trachomatis. The main symptoms are pain in the lower abdomen, fever and purulent discharge from the genital tract. Prompt and adequate diagnosis and implementation of effective treatment is essential to reduce the risk of complications.

Key words: pain in lower abdomen, treatment, infertility, recommendation, Pelvic inflammatory disease, epidemiology